Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
20 hedge funds and large institutions have $5.94M invested in Intellipharmaceuticals International Inc. in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
5% more funds holding
Funds holding: 19 → 20 (+1)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
33% less capital invested
Capital invested by funds: $8.91M → $5.94M (-$2.97M)
64% less call options, than puts
Call options by funds: $161K | Put options by funds: $444K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$210K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$68.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$63.4K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$51.6K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$34.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$905K |
| 2 |
Morgan Stanley
New York
|
-$430K |
| 3 |
Jane Street
New York
|
-$80.4K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$35K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$25.4K |
IPCI Hedge Fund Activity: Q3 2014 in Review
20 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q3 2014, worth a combined $5.94M — down 33% from $8.91M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IPCI positions and 4 closed out — a net gain of 1 holder — while 5 added to existing stakes and 5 trimmed.
The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $210K. The largest seller was Sabby Management, exiting entirely with an estimated $905K sold.
- 20 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q3 2014, up from 19 in Q2 2014.
- Funds reported $5.94M of Intellipharmaceuticals International Inc. stock for Q3 2014, down 33% quarter-over-quarter.
- 5 funds opened new Intellipharmaceuticals International Inc. positions in Q3 2014 and 4 closed out, a net change of +1 holder.
- The largest Intellipharmaceuticals International Inc. buyer in Q3 2014 was DAFNA Capital Management, an estimated $210K added.
- The largest Intellipharmaceuticals International Inc. seller in Q3 2014 was Sabby Management, an estimated $905K sold.
Based on aggregated 13F filings for Q3 2014.